Arbutus Biopharma Corp (ABUS) – Don’t Be So Quick to Call it Dead
Arbutus Biopharma Corp (NASDAQ: ABUS) is 65.20% higher on its value in year-to-date trading and has touched a low of $1.69 and a high of $4.72 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will […]
